CL1-95012-001
22 Nov 2021
CL1-95012-001
NCT05159388
A study of PRS-344/S095012 (PD-L1x4-1BB bispecific antibody) in patients with solid tumors
–
Cancer Type | All cancers |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2021-09-08 |
Anticipated End Date | 2024-11-15 |
Hospital | The Queen Elizabeth Hospital |
---|---|
Clinical Trial Coordinator | Pamela Cooper |
Pamela.cooper@sa.gov.au | |
Phone | 08 8222 6140 |
Principal Investigator | Dr Timothy Price |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs